Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Shares Outstanding (2019 - 2025)

Biodesix (BDSX) has disclosed Shares Outstanding for 7 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 13.44% year-over-year to $8.3 million, compared with a TTM value of $8.3 million through Dec 2025, up 13.44%, and an annual FY2025 reading of $8.3 million, up 13.44% over the prior year.
  • Shares Outstanding was $8.3 million for Q4 2025 at Biodesix, up from $8.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $88.3 million in Q3 2023 and bottomed at $27020.0 in Q3 2021.
  • Average Shares Outstanding over 5 years is $29.1 million, with a median of $17.5 million recorded in 2021.
  • The sharpest move saw Shares Outstanding surged 9799536.36% in 2021, then tumbled 94.95% in 2025.
  • Year by year, Shares Outstanding stood at $30.8 million in 2021, then surged by 152.08% to $77.6 million in 2022, then plummeted by 93.8% to $4.8 million in 2023, then soared by 51.18% to $7.3 million in 2024, then grew by 13.44% to $8.3 million in 2025.
  • Business Quant data shows Shares Outstanding for BDSX at $8.3 million in Q4 2025, $8.0 million in Q3 2025, and $7.3 million in Q2 2025.